Your browser doesn't support javascript.
loading
Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial.
Cohen, Myron S; Nirula, Ajay; Mulligan, Mark J; Novak, Richard M; Marovich, Mary; Yen, Catherine; Stemer, Alexander; Mayer, Stockton M; Wohl, David; Brengle, Blair; Montague, Brian T; Frank, Ian; McCulloh, Russell J; Fichtenbaum, Carl J; Lipson, Brad; Gabra, Nashwa; Ramirez, Julio A; Thai, Christine; Chege, Wairimu; Gomez Lorenzo, Margarita M; Sista, Nirupama; Farrior, Jennifer; Clement, Meredith E; Brown, Elizabeth R; Custer, Kenneth L; Van Naarden, Jacob; Adams, Andrew C; Schade, Andrew E; Dabora, Matan C; Knorr, Jack; Price, Karen L; Sabo, Janelle; Tuttle, Jay L; Klekotka, Paul; Shen, Lei; Skovronsky, Daniel M.
Afiliação
  • Cohen MS; Institute of Global Health and Infectious Diseases, University of North Carolina at Chapel Hill.
  • Nirula A; Eli Lilly and Co, Indianapolis, Indiana.
  • Mulligan MJ; New York University Langone Vaccine Center, Division of Infectious Diseases and Immunology, New York University Grossman School of Medicine, New York, New York.
  • Novak RM; University of Illinois College of Medicine, Chicago.
  • Marovich M; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland.
  • Yen C; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland.
  • Stemer A; Indiana University School of Medicine, Gary.
  • Mayer SM; University of Illinois College of Medicine, Chicago.
  • Wohl D; Institute of Global Health and Infectious Diseases, University of North Carolina at Chapel Hill.
  • Brengle B; Brengle Family Medicine, Indianapolis, Indiana.
  • Montague BT; Division of Infectious Diseases, University of Colorado School of Medicine, Aurora.
  • Frank I; Division of Infectious Diseases, University of Pennsylvania Perelman School of Medicine, Philadelphia.
  • McCulloh RJ; University of Nebraska Medical Center, Omaha.
  • Fichtenbaum CJ; University of Cincinnati Academic Health Center, Cincinnati, Ohio.
  • Lipson B; Florida Primary and Specialty Care, Boca Raton.
  • Gabra N; Burke Internal Medicine & Research, Burke, Virginia.
  • Ramirez JA; Division of Infectious Diseases, University of Louisville School of Medicine, Louisville, Kentucky.
  • Thai C; private practice, Huntington Beach, California.
  • Chege W; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland.
  • Gomez Lorenzo MM; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland.
  • Sista N; FHI 360, Durham, North Carolina.
  • Farrior J; FHI 360, Durham, North Carolina.
  • Clement ME; Louisiana State University Health Sciences Center, New Orleans.
  • Brown ER; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Custer KL; Eli Lilly and Co, Indianapolis, Indiana.
  • Van Naarden J; Eli Lilly and Co, Indianapolis, Indiana.
  • Adams AC; Eli Lilly and Co, Indianapolis, Indiana.
  • Schade AE; Eli Lilly and Co, Indianapolis, Indiana.
  • Dabora MC; Eli Lilly and Co, Indianapolis, Indiana.
  • Knorr J; Eli Lilly and Co, Indianapolis, Indiana.
  • Price KL; Eli Lilly and Co, Indianapolis, Indiana.
  • Sabo J; Eli Lilly and Co, Indianapolis, Indiana.
  • Tuttle JL; Eli Lilly and Co, Indianapolis, Indiana.
  • Klekotka P; Eli Lilly and Co, Indianapolis, Indiana.
  • Shen L; Eli Lilly and Co, Indianapolis, Indiana.
  • Skovronsky DM; Eli Lilly and Co, Indianapolis, Indiana.
JAMA ; 326(1): 46-55, 2021 07 06.
Article em En | MEDLINE | ID: mdl-34081073
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Anticorpos Neutralizantes / Anticorpos Monoclonais Humanizados / COVID-19 Tipo de estudo: Clinical_trials / Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Anticorpos Neutralizantes / Anticorpos Monoclonais Humanizados / COVID-19 Tipo de estudo: Clinical_trials / Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article